Case Report: Successful Post-COVID Severe Peripheral Polyneuropathy Treatment Post AZD1222 ChAdOx1 SARS-CoV-2 Vaccination  

作　　者：Paulo Macio Porto de Melo Rute Alves Pereira e Costa Paulo Macio Porto de Melo;Rute Alves Pereira e Costa(Universidade Nove de Julho, Uninove, São Paulo, Brazil;Sociedade Brasileira de Valorizacao das Sociedades Medicas-Sobemed, São Paulo, Brazil)

机构地区：[1]Universidade Nove de Julho, Uninove, Sã o Paulo, Brazil [2]Sociedade Brasileira de Valorizacao das Sociedades Medicas-Sobemed, Sã o Paulo, Brazil

出　　处：《Case Reports in Clinical Medicine》2022年第5期146-151,共6页临床医学病理报告（英文）

摘　　要：Background: The condition known as polyneuropathy causes peripheral nerve disability, and is characterized by symmetrical distal numbness and paresthesia, often accompanied by pain and weakness. With the advancement of the pandemic in Brazil and in the world, the need for therapies as well as prophylaxis became the main focus in disease control as the viral vector platform vaccine AstraZeneca. Some effects were observed over the period of application. Case Summary: A male patient, 63 years old, previously vaccinated for COVID-19, developed active infection by the virus and in his convalescent period presented intense weakness, with prejudice to his daily activities, including personal hygiene ones. Conclusion: The patient made a complete recovery after combination therapy with testosterone derivates, ivermectin, corticosteroids, and vitamins, besides rehabilitation.Background: The condition known as polyneuropathy causes peripheral nerve disability, and is characterized by symmetrical distal numbness and paresthesia, often accompanied by pain and weakness. With the advancement of the pandemic in Brazil and in the world, the need for therapies as well as prophylaxis became the main focus in disease control as the viral vector platform vaccine AstraZeneca. Some effects were observed over the period of application. Case Summary: A male patient, 63 years old, previously vaccinated for COVID-19, developed active infection by the virus and in his convalescent period presented intense weakness, with prejudice to his daily activities, including personal hygiene ones. Conclusion: The patient made a complete recovery after combination therapy with testosterone derivates, ivermectin, corticosteroids, and vitamins, besides rehabilitation.

关 键 词：COVID-19 Vaccines Case Report CORTICOSTEROIDS TESTOSTERONE IVERMECTIN 

分 类 号：R73[医药卫生—肿瘤]